Back to NVAX
VANGUARD GROUP INC NVAX Position History
Novavax, Inc. • Healthcare
Quarters held
24
Latest value
$95.4M
Q4 2025
Peak value
$121.2M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $567K |
| Q1 2025 | $823K |
| Q1 2025 | $213K |
| Q1 2025 | $376K |
| Q1 2025 | $45 |
| Q1 2025 | $98.5M |
| Q2 2025 | $557K |
| Q2 2025 | $825K |
| Q2 2025 | $210K |
| Q2 2025 | $403K |
| Q2 2025 | $44 |
| Q2 2025 | $95.2M |
| Q3 2025 | $9M |
| Q3 2025 | $121.2M |
| Q3 2025 | $289K |
| Q3 2025 | $554K |
| Q3 2025 | $767K |
| Q3 2025 | $61 |
| Q4 2025 | $594K |
| Q4 2025 | $7.3M |
| Q4 2025 | $224K |
| Q4 2025 | $430K |
| Q4 2025 | $47 |
| Q4 2025 | $95.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $95.4M | 14.20M | — | — |
| Q4 2025 | $47 | 7 | — | — |
| Q4 2025 | $430K | 63.9K | — | — |
| Q4 2025 | $224K | 33.3K | — | — |
| Q4 2025 | $7.3M | 1.08M | — | — |
| Q4 2025 | $594K | 88.4K | — | — |
| Q3 2025 | $61 | 7 | — | — |
| Q3 2025 | $767K | 88.4K | — | — |
| Q3 2025 | $554K | 63.9K | — | — |
| Q3 2025 | $289K | 33.3K | — | — |
| Q3 2025 | $121.2M | 13.98M | — | — |
| Q3 2025 | $9M | 1.03M | — | — |
| Q2 2025 | $95.2M | 15.12M | — | — |
| Q2 2025 | $44 | 7 | — | — |
| Q2 2025 | $403K | 63.9K | — | — |
| Q2 2025 | $210K | 33.3K | — | — |
| Q2 2025 | $825K | 130.9K | — | — |
| Q2 2025 | $557K | 88.4K | — | — |
| Q1 2025 | $98.5M | 15.37M | — | — |
| Q1 2025 | $45 | 7 | — | — |
| Q1 2025 | $376K | 58.6K | — | — |
| Q1 2025 | $213K | 33.3K | — | — |
| Q1 2025 | $823K | 128.4K | — | — |
| Q1 2025 | $567K | 88.4K | — | — |
Other funds holding NVAX
$133.4M
$131.6M
$120.8M
$110.6M
$110.6M
$102.4M
$97.8M